Moving Forward by Looking Back

History of Pharmacy and Pharmaceuticals Pub Date : 2023-10-01 DOI:10.3368/hopp.65.1.33

Patrick Elf, Amy Isham, Dario Leoni

{"title":"Moving Forward by Looking Back","authors":"Patrick Elf, Amy Isham, Dario Leoni","doi":"10.3368/hopp.65.1.33","DOIUrl":null,"url":null,"abstract":"<h3>Abstract</h3> Much has been written in the academic and popular press on the positive consequences of psychedelic-induced mental states. Following the disappearance of psychedelic research from the public eye between the 1970s and early 2000s, a second wave of psychedelic research is gaining increasing interest from private sector actors looking to explore commercial opportunities. The commercialization of psychedelic substances will likely have consequences for how they are used, to what ends, and to what degree of efficacy. We reflect on the critiques of commercialized mindfulness and explore how they may apply to the future of commercialized psychedelics. Mindfulness and psychedelics share several qualities, including their often spiritual origins and self-transcendent nature. However, mindfulness has already undergone a period of commercialization and represents a precedent case for imagining the possible outcomes of the commercialization of psychedelics. By considering the problems associated with separating the practice from its spiritual roots, co-optation to reinforce neoliberal principles, and alterations to administration to cut costs, the article demonstrates the tensions that arise when trying to implement practices rooted in enhancing well-being in societies dominated by consumer capitalism.","PeriodicalId":13221,"journal":{"name":"History of Pharmacy and Pharmaceuticals","volume":"8 1","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-10-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"History of Pharmacy and Pharmaceuticals","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.3368/hopp.65.1.33","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}

引用次数: 0

Abstract

Much has been written in the academic and popular press on the positive consequences of psychedelic-induced mental states. Following the disappearance of psychedelic research from the public eye between the 1970s and early 2000s, a second wave of psychedelic research is gaining increasing interest from private sector actors looking to explore commercial opportunities. The commercialization of psychedelic substances will likely have consequences for how they are used, to what ends, and to what degree of efficacy. We reflect on the critiques of commercialized mindfulness and explore how they may apply to the future of commercialized psychedelics. Mindfulness and psychedelics share several qualities, including their often spiritual origins and self-transcendent nature. However, mindfulness has already undergone a period of commercialization and represents a precedent case for imagining the possible outcomes of the commercialization of psychedelics. By considering the problems associated with separating the practice from its spiritual roots, co-optation to reinforce neoliberal principles, and alterations to administration to cut costs, the article demonstrates the tensions that arise when trying to implement practices rooted in enhancing well-being in societies dominated by consumer capitalism.

查看原文本刊更多论文

回顾过去，向前进

在学术和大众媒体上已经写了很多关于迷幻药引起的精神状态的积极后果。在20世纪70年代至21世纪初迷幻药研究从公众视野中消失之后，第二波迷幻药研究正在吸引越来越多寻求商业机会的私营部门参与者的兴趣。迷幻物质的商业化可能会对它们的使用方式、目的和功效程度产生影响。我们反思了对商业化正念的批评，并探讨了它们如何应用于商业化迷幻药的未来。正念和迷幻药有几个共同点，包括它们通常的精神起源和自我超越的本质。然而，正念已经经历了一段商业化的时期，它代表了一个想象迷幻药商业化可能结果的先例。通过考虑与将实践与其精神根源分离、加强新自由主义原则的合作以及改变管理以削减成本相关的问题，本文展示了在试图实施植根于提高消费资本主义主导的社会福祉的实践时出现的紧张局势。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

History of Pharmacy and Pharmaceuticals

自引率

0.00%

发文量